8 December 2025
Boehringer Ingelheim's JASCAYD® Approved in China for Progressive Pulmonary Fibrosis
JASCAYD® (nerandomilast) gains approval in China for progressive pulmonary fibrosis, offering a new treatment option after five years, based on successful Phase III trials.
